Viewing Study NCT02935257


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2026-06-14 @ 10:37 AM
Study NCT ID: NCT02935257
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2016-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19
Sponsor:
Organization: